VDAC1 and pneumonia: Yes (point mutations in the Ω-loop of lactamase; mutations in Omp35 and Omp36 porin channels and efflux pumps overexpression)Risk of in vivo resistance:-CRRT-pneumonia-septic thrombosis-delayed/absence of source control